Back to TVTX
GOLDMAN SACHS GROUP INC → TVTX
GOLDMAN SACHS GROUP INC TVTX Position History
Travere Therapeutics, Inc. • Healthcare
Quarters held
13
Latest value
$276K
Q2 2026
Peak value
$57.5M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $19.2M |
| Q2 2025 | $3.8M |
| Q3 2025 | $23.8M |
| Q3 2025 | $6.7M |
| Q4 2025 | $14.7M |
| Q4 2025 | $56.7M |
| Q4 2025 | $56.7M |
| Q4 2025 | $14.7M |
| Q1 2026 | $40.5M |
| Q1 2026 | $10.6M |
| Q2 2026 | $57.5M |
| Q2 2026 | $29.5M |
| Q2 2026 | $276K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $276K | 4.9K | — | — |
| Q2 2026 | $29.5M | 518.5K | — | — |
| Q2 2026 | $57.5M | 1.01M | — | — |
| Q1 2026 | $10.6M | 355.2K | — | — |
| Q1 2026 | $40.5M | 1.36M | — | — |
| Q4 2025 | $14.7M | 384.6K | — | — |
| Q4 2025 | $56.7M | 1.48M | — | — |
| Q4 2025 | $56.7M | 1.48M | — | — |
| Q4 2025 | $14.7M | 384.6K | — | — |
| Q3 2025 | $6.7M | 278.8K | — | — |
| Q3 2025 | $23.8M | 995.1K | — | — |
| Q2 2025 | $3.8M | 258.0K | — | — |
| Q2 2025 | $19.2M | 1.30M | — | — |
Other funds holding TVTX
$241.8M
$241.8M
$218.9M
$147.4M
$104.1M